Monday, May 29, 2023
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home CBRNE

Hertfordshire Receives BARDA Award for Mass Casualty Decon Studies

by Global Biodefense Staff
October 2, 2012

The Biomedical Advanced Research and Development Authority (BARDA) earlier this month awarded a two-year research and development contract to the University of Hertfordshire in England for research on mass casualty decontamination. The total value of the award is $5,975,494. 

The university has conducted similar research for the European Union and is generally recognized as the leading research institution for decontamination best practices.

Hertfordshire will conduct advanced studies on key technical aspects of mass casualty decontamination to determine the most effective methods and detergents for decontaminating survivors of a chemical terrorism attack or accident. Current U.S. methods were largely developed through experience in chemical accidents, and without the benefit of thorough scientific studies.

Products will be tested under different conditions such as varying temperatures, flow rates, and volumes of water following chemical agent exposure.

“Bystanders and responders can come in contact with the chemicals released into the environment,” according to statement by the government. “Decontamination, such as washing off the chemical, reduces the amount of the chemical absorbed into the body, decreasing the severity of symptoms and the need for antidotes and medical support.”

The research team also will study in which circumstances decontamination is useful, and whether decontamination creates any secondary negative consequences, such as causing the chemicals to reach other people in the decontamination area.

“The ultimate goal of this work is to support development of scientifically grounded, evidence-based guidance for mass decontamination applicable to U.S. conditions following a chemical event,” said Robin Robinson, Ph.D., director of BARDA. “Decontamination is a first line medical countermeasure which can reduce the need for other medical countermeasures, so we are excited to be able to work with the University of Hertfordshire on this important project.” (PHE.gov)

The award was made on September 12, 2012 under Solicitation Number: BARDA-CBRN-BAA-10-100-SOL-00012.

Tags: ASPRAwardsBARDAHHSMobile Response

Related Posts

Vials of finished vaccines
Funding News

UK Biomanufacturing Fund to Bolster Supply Chain Resilience and Pandemic Preparedness

May 26, 2023
Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA
Funding News

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
two soldiers are in head-to-toe hazmat suits with respirator masks while tending to a mannikin on a stretcher
CBRNE

Protection from Biothreats: DOD to Modernize Medical Countermeasures Development

January 10, 2023
Killing Anthrax More Quickly with Hot Air Decontamination
CBRNE

Killing Anthrax More Quickly with Hot Air Decontamination

January 4, 2023
Load More

Latest News

Vials of finished vaccines

UK Biomanufacturing Fund to Bolster Supply Chain Resilience and Pandemic Preparedness

May 26, 2023
Dr. Sen Pei Discusses Challenges in Forecasting Antimicrobial Resistance

Dr. Sen Pei Discusses Challenges in Forecasting Antimicrobial Resistance

April 26, 2023
Biodefense Headlines – 25 April 2023

Biodefense Headlines – 25 April 2023

April 25, 2023
Aptitude Awarded Up to $54M BARDA Funding for At-Home Diagnostics

Aptitude Awarded Up to $54M BARDA Funding for At-Home Diagnostics

April 20, 2023

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2023 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2023 Stemar Media Group LLC